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Abstract
Objective: Among the many immunosuppressive effects of SDZ RAD (40-0(2-hydroxyethyl)-rapamycin), a rapamycin derivative, is the
inhibition of fibroblast proliferation. Since the long-term success of lung transplantation is limited by the development of bronchiolitis
obliterans, a fibroblast-associated progressive luminal obstruction of the terminal bronchioli, the use of SDZ RAD as immunosuppressive in
pulmonary graft recipients may counteract this process. However, reduction of fibroblast activity, posttransplant, may impair the healing of
the bronchial anastomoses. Materials and methods: The cervical trachea in pigs was denuded, divided and re-anastomosed with Prolene 4-0
single stitches. Control animals (group 1, n ¼ 4) were without, and study animals (group 2, n ¼ 6) were with SDZ RAD therapy
(1.25 mg/kg/day, p.o., 14 days). After 14 days, the pigs were sacrificed. The anastomoses were examined histologically, and breaking
strength of tracheal strips of 5-mm width was measured. Results: All animals survived without complications. Serum levels of SDZ RAD
were 30.9 ^ 8.7 ng/ml (recommended level 20–40 ng/ml). All anastomoses healed macroscopically without difference between the two
groups. Breaking strength was significantly lower in the treated animals (group 1 vs. group 2: 11.75 ^ 0.35 vs. 7.69 ^ 1.39 N, P ¼ 0:01).
Histology did not show a significant change in histoarchitecture between the groups. Conclusions: Although SDZ RAD significantly reduced
the breaking strength of the tracheal anastomosis, no obvious histological differences between treated and untreated animals could be
detected. Since this model does not reflect the clinical situation, further investigations are necessary to reveal the effect of SDZ RAD on
airway wound healing in concert with a contemporary clinically used multidrug immunosuppressive regimen in allograft recipients.
q 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Healing of the bronchial anastomoses has been the
Achilles heel of clinical lung transplantation, with an
associated complication rate of 0–12% and a mortality of
0–4% [1–3]. Although modern surgical approaches have
led to a decreased complication rate [1], in many centers,
insufficiency and stenosis are still frequently encountered;
and despite rapid diagnosis and early intervention and
intensive care, the prognosis is often poor. In spite of
considerable progress in pulmonary transplantation over the
last two decades, several obstacles still remain. Firstly,
cartilage is a bradytrophic tissue, with a low cellular
turnover and slow-healing dynamics. Secondly, the surgical
trauma itself, comprising microlesion and denudation of the
anastomotic plane, impairs re-vascularization. Thirdly,
continuous unspecific immunosuppression as a therapeutic
cornerstone of transplantation medicine may further delay
healing of the anastomoses [4,5].
SDZ RAD (40-0(2-hydroxyethyl)-rapamycin) is a new
analogon of rapamycin with a high immunosuppressive
activity. It inhibits cellular proliferation during mitosis (G1
to S phase). In contrast to ciclosporine, which decreases
interleukin production, it reduces the interleukin-mediated
cellular proliferation.
The potential synergistic effect of SDZ RAD along with
the current triple immunosuppressive regimen used in lung
transplantation – ciclosporine, mycophenol mofetil and
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steroids – is discussed [6]. Since rapamycin has a strong
inhibitive influence on fibroblasts [7,12], which seem to be
instrumental for initiating chronic rejection through the
development of bronchiolitis obliterans (BO), the drug may
hold a promising potential for future first line immuno-
suppression in recipients of pulmonary grafts. However,
since fibroblasts play a central role during the early phase
of wound healing, abrogation of their proliferative cap-
abilities may lead to complications with the bronchial
anastomoses.
In this study, we have evaluated the influence of SDZ
RAD – without rejection phenomena – on the healing
process of airway anastomoses.
2. Materials and methods
2.1. Animals and groups
In ten pigs (24–31 kg, 3–4 months), the cervical trachea
was transected and re-anastomosed. After surgery, the
animals were randomized into two groups: group 1 ðn ¼ 4Þ
animals were untreated and served as the control group; group
2 ðn ¼ 6Þ animals were treated with 1.25 mg/kg/day SDZ
RAD orally (generously provided by Novartis Pharma,
Switzerland) during the 14-day observation period. All
animals received antibiotic prophylaxis with chlortetra-
cycline, tylosin and sulfadimidine (CAS), 8 g/kg feed, 5
days prior to surgery.
2.2. Surgical procedure
The pigs were intubated and ventilated with 100%
oxygen (FIO2: 1.0) during the intervention. Inhalative gas
narcosis was performed with isoflurane (Abbott, Switzer-
land) at concentrations between 0.2 and 1.5%. All
procedures were performed under sterile conditions with
the animals fixed in supine position. After cervical
exposure, the first six rings of the trachea were dissected
free from the surrounding tissue. Between the third and
fourth ring, the tracheal continuity was cut over 80% of its
circumference to simulate local ischemia. The anastomoses
were performed with Prolene 4-0 (Ethicon, Johnson &
Johnson Medical, Switzerland), single stitches. The wound
was closed layer by layer with Vicryl 3-0 (Ethicon, Johnson
& Johnson Medical), and the skin with Dermalon 4-0
(USSDG, TYCO Healthcare, Switzerland). The duration of
the procedure was 30 min.
2.3. General postoperative care
Antibiotic prophylaxis with CAS (8 g/kg feed), was
continued over 5 days postoperatively. All animals received
analgesics on a fixed schedule for 1 week. Blood samples
including hematological parameters and SDZ RAD trough
levels were taken at days 3, 7, 10 and 14. The animals were
visited twice a day. On day 14, the animals were sacrificed
and the cervical trachea removed. All animals received
humane care in accordance with the ‘Guide for the Care and
Use of Laboratory Animals’ (National Institutes of Health
publication 85-23, revised 1985). The study protocol was
approved by the local animal study committee.
2.4. Macroscopic and biomechanical evaluations
The anastomoses were inspected and the trachea was cut
into strips of 5 mm width. The suture material was carefully
removed, and breaking strength of two strips of trachea and
skin for each animal was measured. The specimen was fixed
at a spring balance and tension was continuously increased
until the specimen ruptured.
2.5. Histological evaluation
Tissue specimens were fixed in 4% neutral buffered
aqueous formaldehyde solution. From each specimen, two
longitudinal sections were taken, comprising the processed
and paraffin-embedded anastomosis were taken using
routine procedures. A 2 mm section was cut from each
paraffin tissue block and stained with hematoxylin–eosin,
elastic Van Gieson and alcian blue–periodic acid–Schiff for
routine light microscopic evaluation. The site of the
anastomosis was assessed morphologically for fibrosis,
occurrence of granulation tissue, infiltration by lymphocy-
tes/histiocytes and by neutrophils as none (0), mild (1þ ),
moderate (2þ ), or severe (3þ ). All sections were examined
by a pathologist (A.G.) who was blinded toward the
treatment protocol (Table 1).
2.6. Statistics
Data analysis was performed with the Statview for
Applew 5.0.1 (SAS Institute Inc., USA). The data are
expressed as mean values ^ standard deviation. We
performed ANOVA to compare the two groups. A P value
,0.05 was considered significant.
3. Results
3.1. General data
There was no difference between the two groups in terms
of postoperative course, general condition and wound
healing. No local infection was encountered and none of
the animals developed airway stenosis or associated
pulmonary problems. SDZ RAD serum levels were
30.9 ^ 8.7 ng/ml (recommended level 20–40 ng/ml).
Fourteen days after surgery, the animals were sacrificed
and the cervical trachea removed. At time of sacrifice, skin
incision, trachea and peritracheal tissue had completely
healed in both groups. The anastomotic region could not be
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detected by bronchoscopy. None of the animals showed
stenosis of the trachea or intraluminal hypergranulation. The
Prolene stitches were easy to remove without injuring the
trachea and the surrounding tissue at the site of anastomosis.
The breaking strength of the trachea was measured using
strips of 5-mm diameter (two for each animal; Fig. 2).
Animals in the treated group (group 2) displayed a
significantly reduced anastomotic breaking strength (group
2: 6.68 ^ 1.39 N) as compared with untreated animals
(group 1: 11.75 ^ 0.35 N; P ¼ 0:008). In two of the four
untreated animals, the rupture occurred adjacent to, but not
at the anastomosis. For the skin strips, we found a reduced
breaking strength too, yet without statistical significance
(group 1: 31.0 ^ 8.1 N vs. group 2: 19.38 ^ 6.2 N,
P ¼ 0:116).
3.2. Histology
The sections from the treated animals (Fig. 1) showed
mild mucosal fibrosis in four, and severe fibrosis in two
cases. There was no granulation tissue in three cases, little
granulation tissue in two cases and moderate granulation
tissue one case. The infiltration by lymphocytes/histiocytes
was mild in three and moderate in another three cases as
well. There was no infiltration by neutrophils in four, and a
mild and a moderate infiltration in another two cases.
The sections from the control animals (Fig. 2) revealed
mild mucosal fibrosis in two, moderate fibrosis in one and
severe fibrosis in one case. There was no granulation tissue
in three cases and moderate granulation tissue in one
animal. The infiltration by lymphocytes/histiocytes was
mild in three and moderate in one case. There were no
neutrophils in three cases, and there was a mild infiltration
by neutrophils in one case. The cartilaginous part of the
trachea was inconspicuous in both groups. Altogether, the
interindividual differences were greater than the variances
between the two groups.
4. Discussion
Rapamycin (Sirolimusw) is an immunosuppressive agent
produced by fermentation of Streptomyces hygroscopicus
[9]. Its derivative, SDZ RAD, has similar immunosuppres-
sive properties; however, the pharmacokinetics consist of a
shorter terminal half-life and a better oral bioavailability in
man [8]. The immunosuppressive properties of SDZ RAD,
especially in combination with ciclosporine and FK506, are
well documented [10,11].
Like rapamycin, SDZ RAD inhibits growth factor-
mediated proliferation of non-immune cells: it blocks
basic fibroblast growth factor (bFGF)-induced proliferation
of bovine aortic and human umbilical vein endothelial cells
and 3T3 fibroblasts; it also inhibits bFGF and platelet-
derived growth factor (PDGF)-stimulated proliferation of
smooth muscle cells [7,12].
After lung transplantation, long-term survival is limited
by the development of obliterative bronchiolitis (OB). OB
causes a decline of lung function that is refractory to therapy
and often culminates in respiratory failure within months of
its onset. Pathologically, OB is a partial or complete luminal
obliteration of the terminal bronchioli by dense fibrous
scarring, resulting from proliferation of fibroblasts. Since
SDZ RAD inhibits fibroblast proliferative capabilities, it
has been proposed as an ideal first line immunosuppressant
in clinical lung transplantation. On the other hand, this
unspecific impairment of fibroblast function could also
affect the general quality of wound healing following
engraftment. Theoretically, the region with the slowest
proliferative turnover – the bronchial anastomoses – may
Table 1
Morphological assessment of the anastomotic site for fibrosis, occurrence of granulation tissue, infiltration by lymphocytes/histiocytes and by neutrophils
Animal
hist
Mucosal fibrosis neutrophils Occurrence of granulation tissue Infiltration by lycy/hist Infiltration by neutrophils Breaking strength
(N)
Trachea Skin
T 1 þ 0 1 þ 0 6.75 na
T 1 þ 0 1 þ 0 5.25 22.50
T 3 þ 2 þ 2 þ 2 þ 8.00 26.25
T 3 þ 1 þ 2 þ 1 þ 7.75 16.25
T 1 þ 0 1 þ 0 5.75 12.50
T 1 þ 1 þ 2 þ 0 9.00 17.00
C 1 þ 0 1 þ 0 11.5a na
C 2 þ 0 1 þ 0 11.50 36.75
C 3 þ 2 þ 2 þ 1 þ 12a 25.25
C 1 þ 0 1 þ 0 13.00 21.25
Despite the fact that the breaking strength of the treated animals was significantly reduced, no histological correlation could be found. The interindividual
histological differences were higher than the differences between the groups.
Classification of the pathological changes: 0, none; 1 þ , mild; 2 þ , moderate; 3 þ , severe.
Abbreviations used: lycy, lymphocytes; hist, histiocytes; sqmet, squamous metaplasia.
a The trachea did not rupture at the anastomotic site in one of the samples.
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be the most susceptible toward SDZ RAD-mediated
fibroblast inhibition. In order to disclose the isolated
influence on bronchial anastomotic healing by SDZ RAD,
we devised a simplified model with tracheal anastomoses.
The trachea is surgically easier to access, and since there is
no structural difference between trachea and main bronchi,
the impact of SDZ RAD treatment is supposedly the same.
Performing an in situ repair, rather than an allogenic
transplantation, we could rule out any additional alloanti-
gen-triggered immune phenomenon.
Macroscopically, cartilage and mucosa in both groups
had healed well, without any lesions at the time of sacrifice.
The evaluation of the histomorphological anastomotic
architecture did not show marked differences between the
groups; as a matter of fact, greater interindividual, rather
than intergroup, differences were detected. When we
measured breaking strength, however, we found a statistical
significant reduction in the SDZ RAD group. Although we
were able to demonstrate a biological significance between
the groups – applied to the clinical setup – no differences
between SDZ RAD treated and untreated animals could be
demonstrated. Still, the fact that mechanical stress tests on
anastomoses in the treated group showed significantly lower
results implies – in spite of the unspecific morhphologic
differences – an altered, yet undetected ultrastructural
change. Possibly, rapamycin treatment may affect the
extracellular component synthesis of chondrocytes and
fibroblasts, thereby impairing mechanical properties of the
surrounding matrix. In addition, the applied time frame in
our setup should be taken into consideration. At 2 weeks,
when the anastomoses were analyzed, structural stability
was still aided by the intact suture materials. Assessment of
the bronchial anastomoses at a later time point, and/or the
influence of other immunosuppressive agents, may also
influence the clinical course. The model itself has
limitations. First of all, the tracheal anastomosis is different
from the bronchial anastomosis. In lung transplantation, the
blood supply of the donor main bronchi is very low, whereas
in tracheal anastomoses, tension can be a limiting factor.
In summary, our data suggest a biologically significant,
SDZ RAD-mediated reduction of mechanical strength in
tracheal anastomoses. Since macroscopic inspection and
histological evaluation did not show marked differences, the
observed phenomenon does not have clinical significance in
the investigated setup. In order to estimate the influence of
rapamycin on anastomotic healing in a more clinical
relevant model, SDZ RAD should be investigated in the
context with a standard immunosuppressive regimen,
possibly in recipients of lung allografts with bronchial
anastomoses.
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Appendix A. Conference discussion
Dr A. Haverich (Hannover, Germany): I liked this presentation very
much because it shows a very clean experimental design, also very clear
results. However, what you state in the outlook is very obvious. If you
would have put in a cocktail of immunosuppressive agents in this
experimental model, the results would have been quite different. This
experimental design would clearly have mimicked more the clinical
situation. Would you comment on that?
Dr Korom: Yes, obviously, but still, as you stated, in the first set of these
experiments, we just wanted to assess the clear-cut influence of rapamycin.
And, in addition, what should be taken into account, especially using an
allograft model, go even one step further, adding an inflammatory reaction
to that area, which adds another dimension of entropy to that level. Then it
is even harder to decipher that which of the effects was rapamycin-induced.
Dr W. Weder: I want to briefly add to Dr Korom’s comments that these
follow-up experiments are in preparation.
Mr J. Thorpe (Leeds, UK): You mentioned there was a change in the
intracellular matrix in terms of the fibroblastic activity. Was there much less
activity, because this will have connotations not just for lung transplan-
tation but for any tracheal resection? Can you comment on what the
fibroblastic activity was like in the treatment group?
Dr Korom: Again, these investigations are under way. We are analyzing
with PCR the composition of extracellular matrix in these areas, and, as a
matter of fact, we have not yet isolated fibroblasts from these areas. We are
planning to take them ex vivo and assess their activities and secretion
dynamics. But we are in the process, and maybe a year from now we can
satisfy your curiosity.
Dr S. Guth (Mainz, Germany): If I understand you right, you stated that
you only cut 80% of the trachea?
Dr Korom: Right.
Dr Guth: How was the set-up of the examination of the breaking
strength?
Dr Korom: We used a spring balance and the weight was gradually
increased, and we measured strips of 0.5 cm diameter, including the
anastomosis. We put them up, increased the weight and measured the
breaking strength needed and they all broke at the anastomosis, except for
one.
Dr Guth: And why didn’t you cut the whole trachea?
Dr Korom: We only cut 80% of the trachea for surgical ease.
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